Previous 10 | Next 10 |
Channelchek news releases related Channelchek news releases and Channelchek press releases from 08/13/21 12:00:00 on US and Canada Markets.
Over achieves Q2 expectations. Revenues increased a solid 18.4% to $49.3 million, beating our estimate of $44.8 million by 10%. Given tight expense controls, adjusted EBITDA was $4.4 million, an increase of over 800% from the year earlier, out performing our estimate by nearly 100%. Each opera...
AUSTIN, Texas, Aug. 12, 2021 /PRNewswire/ -- Harte Hanks, Inc. (OTCQX: HRTH), an industry leader in data-driven, omnichannel marketing, today announced financial results for the second quarter ended June 30, 2021. Read More >>
2Q21. Revenue of $1.26 billion was up 29% year-over-year (26.2% in constant currency) driven by increased customer demand as the economy recovers and a 310 bp impact from Softworld. Kelly reported operating earnings of $13.7 million, up 24.1% y-o-y, and up 29.3% sequentially. GAAP EPS for 2Q21...
2Q21 Results. Revenue totaled $14.9 million, up 12% sequentially and 28% year-over-year. OSS reported GAAP EPS of $0.09 compared to $0.00 last year. Adjusted EPS for the second quarter of 2021 was $0.04, compared to $0.01 last year. Adjusted EBITDA rose to $1.4 million, up $1.3 million year-ov...
Onconova Reported 1Q21 and Updated Its Clinical Trial Progress Onconova reported a net loss of $4.2 million or $(0.27) per share for 2Q21, ended June 30. Cash on hand was $43.7 million, which we project to be sufficient for operations through 2023. The company gave updates on the clinical prog...
2Q21 Results. Revenue totaled $14.9 million, up 12% sequentially and 28% year-over-year. OSS reported GAAP EPS of $0.09 compared to $0.00 last year. Adjusted EPS for the second quarter of 2021 was $0.04, compared to $0.01 last year. Adjusted EBITDA rose to $1.4 million, up $1.3 million year-ov...
NEWTOWN, Pa., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended June 30, 2021. Read M...
Significant Data Was Presented In 2Q21. PDS Biotechnology reported 2Q21 loss of $0.6 million or $(0.03) per share. Importantly, interim Phase 2 data from the lead trial for PDS0101 presented at the ASCO conference showed strong indications of efficacy. Additional data from this PDS0101 trial a...
2Q2021 Results Above Expectations and 3Q2021 Off to Good Start. 2Q2021 EBITDA of $21.4 million was above expectations by $3.4 million mainly due to lower opex and charter hire expenses which more than offset variances in TCE rates and shipping days of 4,723. It is challenging to keep up in ris...
ESCONDIDO, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (Nasdaq: OSS), a leader in AI Transportable solutions on the edge, reported results for the second quarter ended June 30, 2021. All quarterly comparisons are to the same year-ago period unless otherwise noted. The comp...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
25.97%Change Percent:
LogicMark Inc Com Par$ (New) Company Name:
LGMK Stock Symbol:
NASDAQ Market:
logicmark.com Website: